Animal AMR and Human Disease: Evidence for One Health Action
The NIHR-funded VacAMR Global Health Research Group, in collaboration with the International Society for Infectious Diseases (ISID), continued its webinar series with a session exploring the connection between animal AMR and human disease. The webinar, titled “Linking Animal AMR to Human Disease: Evidence and Strategies to Disrupt Zoonotic AMR Transmission,” was held on 22 June 2026. The webinar brought together researchers, clinicians, veterinarians, microbiologists, public health professionals, policymakers, and students from around the world to discuss practical One Health approaches to reducing the emergence and spread of antimicrobial resistance across human, animal, and environmental interfaces.
The webinar featured Professor Sam Kariuki, Africa Continental Lead and Office Director at the Drugs for Neglected Diseases initiative (DNDi), Nairobi, Kenya, and one of Africa’s foremost experts in infectious diseases, antimicrobial resistance, and microbial genomics. Drawing on more than two decades of research and public health leadership, Professor Kariuki provided a comprehensive overview of the scientific evidence linking antimicrobial use in animals to resistant infections affecting humans, while emphasizing practical strategies to interrupt these transmission pathways.
Professor Kariuki opened the session by highlighting antimicrobial resistance as one of the greatest threats to global health, food security, and sustainable development. He noted that while antimicrobials remain indispensable for protecting both human and animal health, their inappropriate and excessive use has accelerated the emergence of resistant pathogens that now compromise the effectiveness of essential medicines. He emphasized that AMR is not confined to hospitals or healthcare settings but is driven by interconnected ecological systems where humans, domestic animals, wildlife, food production systems, and the environment continuously interact.
A central focus of the presentation was the growing body of evidence demonstrating that resistant bacteria and antimicrobial resistance genes circulate between animals and humans through multiple pathways. Professor Kariuki discussed the role of livestock, companion animals, wildlife, aquaculture, food products, water sources, and environmental contamination in facilitating the transmission of resistant organisms. Advances in whole genome sequencing and molecular epidemiology have increasingly confirmed that many resistant bacterial strains and resistance genes are shared across these sectors, reinforcing the need for integrated surveillance under a One Health framework.
The webinar further explored the importance of strengthening surveillance systems capable of monitoring antimicrobial use, antimicrobial resistance, and pathogen transmission across both veterinary and human health sectors. Professor Kariuki highlighted how genomic surveillance has transformed our understanding of AMR epidemiology by enabling the identification of transmission networks, emerging resistance mechanisms, and cross-border dissemination of priority pathogens. He emphasized that integrated surveillance provides critical evidence for informing policy, guiding stewardship interventions, and supporting timely public health action.